Overview

Imaging CRF X NOP Interactions in CUD

Status:
Recruiting
Trial end date:
2028-09-01
Target enrollment:
0
Participant gender:
All
Summary
This study uses [11C]NOP-1A positron emission tomography (PET) and a hydrocortisone challenge to image the interaction between nociceptive opioid peptide (NOP) receptors and cortisol/corticotrophin releasing factor (CRF) in subjects with cocaine use disorders (CUD) and matched healthy controls (HC). It will also examine whether alterations in CRF x NOP interactions predict relapse in subjects with CUD.
Phase:
Early Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Rajesh Narendran
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Hydrocortisone hemisuccinate
Criteria
Cocaine use disorders (CUD)

1. Males or females between 18 and 55 years old

2. Fulfil DSM-5 criteria for cocaine use disorder

3. No other current DSM-5 psychiatric or addictive disorders (such as major depressive
disorder, bipolar disorders, psychotic disorders, etc.,)

4. No current abuse (six months) of opiates, sedative-hypnotics, amphetamines, MDMA,
etc., as well as moderate to severe alcohol or cannabis use (twice a week). Nicotine
use will be quantified and controlled between groups using the Fagerstrom Test for
Nicotine Dependence (Heatherton et al., 1991);

5. Not currently on prescription medical or psychotropic medications

6. No current or past severe medical, endocrine or neurological illnesses including
glaucoma, seizure disorders, hypertension, hypercholesterolemia as assessed by a
complete medical history and physical

7. Not currently pregnant or breastfeeding

8. No history of significant radioactivity exposure in past year from another research
study or occupation that exceeds RDRC guidelines

9. No metallic objects in the body that are contraindicated for MRI

Healthy Controls (HC)

1. Males or females between 18 and 55 years old

2. No present or past DSM-5 disorders (other than nicotine dependence)

3. Criteria 5 to 9 as listed previously.